JASON YOUNG: Open Payments
NPI 1205224870 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 42 payments from 14 companies in 2025. Trend: 2023 $65 · 2024 $236 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $148 |
| Amgen Inc. | 6 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Dexcom, Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $44 |
| Inspire Medical Systems, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Biogen, Inc. | 1 | $19 |
Products named: QULIPTA, OTEZLA, Kerendia, Dexcom G6 Transmitter, MOUNJARO, UBRELVY, INSPIRE, Ozempic.
Industry payments across AR — which companies pay providers there.
